medigraphic.com
Colegio de Medicos y Cirujanos República de Costa Rica

2013, Number 607

<< Back Next >>

Rev Med Cos Cen 2013; 70 (607)

Síndrome de fatiga crónica

Cubillo BB

Language: Spanish
References: 10
Page: 423-428
PDF size: 209.67 Kb.


ABSTRACT

Chronic Fatigue Syndrome is characterized by a profound and disabling fatigue, accompanied by several other symptoms, resulting in a significant functional impairment with a reduction in occupational, personal, social and educational status. There are a constellation of pathophysiological abnormalities, suggesting that the syndrome is a heterogeneous condition with a complex and multifactorial etiology. Although there is a significant comorbidity with psychiatric disorders, CFS should be considered an independent entity, however the patient perception and coping skills can perpetuate the illness. Treatment is symptom based with pharmacological and behavioural interventions. Cognitive behavioural techniques and graded exercise con be effective. The assessment and treatment of the CFS should be multi dimensional and tailored to the needs of the individual patient.


REFERENCES

  1. El síndrome de fatiga crónica (SFC) http://www.cdc.gov/cfs/es/index.html

  2. El síndrome de fatiga crónica y su diagnóstico en Medicina Interna: F. J. Barbado Hernández, J. Gómez Cerezo, M. López Rodríguez, J. J. Vázquez Rodríguez. Anales de Medicina Internaversión impresa ISSN 0212- 7199. An. Med. Interna (Madrid) v.23 n.5 Madrid mayo 2006.

  3. Fukuda K, Strauss S, Hickie I, Sharpe M, Dobbins J, Komaroff A. The chronic fatigue syndrome: a comprehensive approach to its definition and study. Annals of Internal Medicine 1994; 121: 943-9

  4. Forsyth LM, Preuss HG, MacDowell AL, et al. Therapeutic effects of oral NADH on the symptoms of patients with chronic fatigue syndrome. Ann Allergy . 1999;82:185 - 191.

  5. Harrison Principios de Medicina Interna, 17a edición. Parte 16. Trastornos neurológicos > Sección 4. Síndrome de fatiga crónica. Capítulo 384. Síndrome de fatiga crónica http://harrisonmedicina. com/content.aspx?aid=4505128

  6. Medline Plus. Un servicio de la Biblioteca Nacional de Medicina de EE.UU. Institutos Nacionales de la Salud http://www nlm.nih.gov/medlineplus/ spanish/ency/article/001244 htm

  7. .Neinstein LS. Adolescent Health Care. A Practical Guide. Fifth Edition. Philadelphia: Lippincott-Williams- Wilkins; 2008.

  8. Royal College of Paediatrics & Child Health. Evidence Based Guideline for the Management of CFS/ME (Chronic Fatigue Syndrome/Myalgic Encephalopathy) in Children and Young People. 2004. London, Royal College of Paediatrics and Child Health.

  9. Turnbull N, Shaw EJ, Baker R, Dunsdon S, Costin N, Britton G, Kuntze S and Norman R (2007). Chronic fatigue syndrome/ myalgic encephalomyelitis (or encephalopathy): diagnosis and management of chronic fatigue syndrome/myalgic encephalomyelitis (or encephalopathy) in adults and children. London: Royal College of General Practitioners. NICE Full Guidance.

  10. Warren G, McKendrick M, Peet M. The role of essential fatty acids in chronic fatigue syndrome. A case-controlled study of red-cell membrane essential fatty acids (EFA) and a placebo-controlled treatment study with high dose of EFA. Acta Neurol Scand . 1999;99:112 - 116.




2020     |     www.medigraphic.com